20 Maxwell House, Singapore, Jan. 25, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global gene therapy market is expected to clock US$ 4.64 billion by 2030 and to grow at a CAGR of 8.1%…
Breadcrumb Trail Links PMN Business Author of the article: Reuters Julie Steenhuysen and Deena Beasley Published Jan 07, 2023 • 4 minute read Join the conversation Article content The U.S. Food and…
Two US congressional committees have accused the Food and Drug Administration of inappropriately collaborating with Biogen before approving the company’s Alzheimer’s drug.A joint report by the House committees on Oversight and…
Pune, Dec. 15, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global central nervous system treatment market is expected to clock US$ 191.01 billion by 2030 and to grow at a CAGR of 9.10%…
Breadcrumb Trail Links PMN Business Author of the article: Publishing date: Nov 29, 2022 • 0 minutes ago • 3 minute read Join the conversation Article content SAN FRANCISCO — An experimental Alzheimer’s…
By TOM MURPHY - AP Health Writer
Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the…
Pune, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global neurodegenerative disease drugs market is expected to clock US$ 77.01 Billion by 2030 and to grow at a CAGR of 6.8%…
CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BIIB800, a biosimilar candidate referencing…